About

VP Sales UKI

Scott joins PulmOne after serving in senior sales positions at Pulmonx (NASDAQ:LUNG) over the past 8 years. In his various roles at Pulmonx, he successfully participated in the adoption and growth of Bronchoscopic Lung Volume Reduction in UKI, Nordics & BENELUX, and assisted in the NHS England Specialised Commissioning of Lung Volume Reduction.

Previously, Scott held positions with medical device companies Lombard Medical, Atrium Medical/Maquet and Vygon.

Scott studied Sport & Exercise Science at Leeds Metropolitan University and received a Post Graduate Certificate in Business Management from the London School of Business and Finance.

VP Business Development

Prof. Jeffrey J. Fredberg is a professor of BioEngineering and Physiology at the Harvard School of Public Health. He joined PulmOne’s Scientific Advisory Board in 2010.

Prof. Fredberg served on the editorial boards of the Journal of Applied Physiology, Respiratory Research, American Journal of Physiology and Mechanics & Chemistry of Biosystems.

Prof. Fredberg’s many past and present roles include serving on the ATS board of directors, NIH Respiratory Sciences Study Section Boundary Team, the NSF/NIH Interagency Panel on Bridging the Life and Physical Sciences, the NHLBI Working Group on Nanotechnology in Heart, Lung, Blood, and Sleep Medicine, and the Heart, Lung, and Blood Program Project Review Committee (study section HLBP) of the NHLBI.

VP Sales, Japan

Keisuke has over 25 years’ sales and marketing leadership experience including new product launches and development of new market segments. He started his career in sales and received top sales awards from E.&J. Gallo and Boston Scientific. In marketing roles, he successfully launched a new neurosurgical shunt system, assisted a multi-center clinical study and achieved V-shaped recovery for B/Braun Aesculap. He also held several leadership roles in Emergency Care, Digestive Surgery and Sterilization. Keisuke graduated from Azusa Pacific University in California with a BA in Business Administration.

VP Operations & Engineering

Amit Morag has 15 years of experience in the high technology industry. Prior to joining PulmOne, Amit served in various Operations, Engineering, Service and Product leadership roles, mainly in the medical devices and telecommunications industries, including General Electric Healthcare. Amit holds a B.Sc in Engineering and MBA, both from Tel-Aviv University.

VP Customer Service & Product Mgmt

Robert Pelfrey, DHSc, RRT-ACCS, RPFT, NPS, AE-C has worked as a registered respiratory therapist for the past 16 years. Before joining PulmOne, Robert was a hospital manager of respiratory care, pulmonary function therapy, and a sleep laboratory. He also teaches at the university level as adjunct faculty in the field of cardiopulmonary/renal anatomy and physiology. Additionally, Robert serves on the State of Ohio Medical Board as a member of the Ohio Respiratory Care Advisory Council. Robert holds a Doctor of Health Science from Nova Southeastern University, a Master’s degree from Cleveland State University, and a Bachelor’s degree from Bowling Green State University.

VP Sales Rest of World

Eran has extensive experience leading Sales, Marketing and Business Development teams in medical devices companies. Prior to joining PulmOne he was VP International Sales and Marketing at Allium Medical (TLV: ALMD). Previously he held senior management positions at companies including Persys Medical, Johnson & Johnson, and others. Eran holds an M.A. in Marketing Communications Management from the University of Westminster.

CEO

Avi Lazar founded PulmOne Advanced Medical Devices Ltd. in March 2006, and has been serving as CEO since its inception. Prior to PulmOne, Avi served as Chief Executive Officer and Chief Financial Officer in several Israeli technology companies, where he was instrumental in raising over $50 million from prominent financial and strategic investors, such as Cisco Systems, Lehman Brothers, Philips, JP Morgan Partners, Texas Instruments, ABN Amro and others. Avi has also served on a number of Boards. Before these corporate activities, Avi held senior positions with international accounting firm Ernst & Young, where he was responsible for several successful initial public offerings in NASDAQ and TASE.

Prof. Robert Brown is Director of Pulmonary Function Laboratory and the Medical Director of the Respiratory Acute Care Unit at the Massachusetts General Hospital, and an Associate Professor of Medicine at Harvard Medical School. He joined PulmOne’s Scientific Advisory Board in 2010.

Prof. Brown served on the editorial boards of Medicine International, the Journal of the American Paraplegia Society (section editor), the Journal of Spinal Cord Injury Medicine (section editor), the Journal of Spinal Cord Injury Medicine (associate editor) and the Archives of Physical Medicine and Rehabilitation.